1,6,11(2H)-Naphthacenetrione,4-[(6-deoxy-2-O-methyl-a-L-mannopyranosyl)oxy]-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl-,(2S,3S,4R)-

Suppliers

Names

[ Name ]:
1,6,11(2H)-Naphthacenetrione,4-[(6-deoxy-2-O-methyl-a-L-mannopyranosyl)oxy]-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl-,(2S,3S,4R)-

[Synonym ]:
Steffimycinum [INN-Latin]
Steffimycine [INN-French]
Steffisburgensimycin
Estefimicina [INN-Spanish]
Steffimycin

Chemical & Physical Properties

[ Density]:
1.58g/cm3

[ Boiling Point ]:
813.7ºC at 760mmHg

[ Molecular Formula ]:
C₂₈H₃₀O₁₃

[ Molecular Weight ]:
574.53000

[ Flash Point ]:
269.3ºC

[ Exact Mass ]:
574.16900

[ PSA ]:
198.51000

[ LogP ]:
0.38340

[ Vapour Pressure ]:
5.49E-28mmHg at 25°C

[ Index of Refraction ]:
1.673

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: QI9456000

CHEMICAL NAME :: 1,6,11(2H)-Naphthacenetrione, 4-((6-deoxy-2-O-methyl-alpha-L-mannopyranosyl)oxy)-3, 4-dihydro- 3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl-

CAS REGISTRY NUMBER :: 11033-34-4

LAST UPDATED :: 199612

DATA ITEMS CITED :: 3

MOLECULAR FORMULA :: C28-H30-O13

MOLECULAR WEIGHT :: 574.58

WISWESSER LINE NOTATION :: L E6 C666 BV FV MVT&&&J GQ G1 HO1 KQ OQ QO1 IO- BT6OTJ CO1 DQ EQ F1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Mammal - species unspecified

DOSE/DURATION :: 562 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :: DNA adduct

TEST SYSTEM :: Mammal - species unspecified Lymphocyte

DOSE/DURATION :: 4500 nmol/L

REFERENCE :: CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year: 25,59,1979

Related Compounds

2,4-difluoro-N-(2-(6-oxo-3-(pyridin-4-yl)pyridazin-1(6H)-yl)ethyl)benzenesulfonamide
N-(2-(6-oxo-3-(pyridin-4-yl)pyridazin-1(6H)-yl)ethyl)-4-(trifluoromethoxy)benzenesulfonamide
2,4-diethoxy-N-(2-(6-oxo-3-(pyridin-4-yl)pyridazin-1(6H)-yl)ethyl)benzenesulfonamide
4-fluoro-3-methyl-N-(2-(6-oxo-3-(pyridin-4-yl)pyridazin-1(6H)-yl)ethyl)benzenesulfonamide
4-Bromo-2-(thiophen-3-YL)pyridine
2-(2,4-difluorophenoxy)-N-(2-(6-oxo-3-(pyridin-4-yl)pyridazin-1(6H)-yl)ethyl)acetamide
(1R,2R,4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-1-hydroxy-9-(hydroxymethyl)-10-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
1-(4-ethoxyphenyl)-3-(2-(6-oxo-3-(pyridin-4-yl)pyridazin-1(6H)-yl)ethyl)urea
2,3-dimethoxy-N-(3-(6-oxo-3-(pyridin-3-yl)pyridazin-1(6H)-yl)propyl)benzamide
3,4-difluoro-N-(3-(6-oxo-3-(pyridin-3-yl)pyridazin-1(6H)-yl)propyl)benzamide

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.